Pre-clinical & Clinical Bioanalysis · GLP & GCP Compliant

Comprehensive preclinical and clinical services designed to ensure GLP and GCP compliance.

Services

All Pre-clinical & Clinical Bioanalysis Services

Sample preparation biology bioanalytics

Bioanalysis of Biologics and Biosimilars

Method development and validation and sample measurement of biologics and biosimilars.

Oligo testing

Bioanalysis of Nucleic Acids

Quantification of nucleic acids as therapeutics, biomarkers or similar with standardized and reproducible methods according to GLP.

Small molecules

Bioanalysis of Small Molecules & Generics

Development and validation of analytical methods for analysis of biological samples delivered mainly from pre-clinical and clinical studies.

LC-MSMS Sciex API 5500 QTrap

Bioequivalence Studies

Bioanalysis for bioequivalence studies of generics in collaboration with the sponsor and/or the selected clinical phase centre.

Percutaneous Absorption

Percutaneous Absorption

Percutaneous absorption assays for topical semisolid drug products: In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT)

Sample preparation MS

Determination of Enzyme Activity

Determination of active enzymes and enzymatic biomarkers in biological and formulation samples according to GLP.

Biomarker Analysis

Biomarker analysis services across various therapeutic areas aided by our state-of-the-art equipment and multiplexing techniques.

Pharmakokinetic Evaluation

Pharmacokinetic Evaluation & Statistics

Pharmacokinetic calculations and statistics of bioanalytical data from preclinical and clinical studies with Phoenix WinNonlin®.

Histopathology

Histopathology Services

GLP-certified histopathology evaluation and consultancy services through our strategic partner Patconsult in order to complement our preclinical bioanalytical offer.

Ready to accelerate your drug development?
Let’s tailor the perfect solution for you!

Ask our experts

testimonial-cta-background

Yong Suk Yang

Global QC Operation Team Manager

celltrion-logo
quotation-mark

We are currently developing multiple new biosimilar projects and consider Kymos one of the best CROs in Europe for drug release and testing

Dr. Dino Mangion

Head of Malta Operations

Combino Logo
quotation-mark

We were positively impressed when Kymos reacted to our needs by investing in their stability capabilities, and now, two years down the line, with projects in full-swing, I can safely say that we made the right choice. In Kymos we have found a reliable, committed, trustworthy and professional partner.

Dr. Marius Strunk

Senior Pharmaceutical Development Manager

Helm Logo
quotation-mark

Back in 2017 there weren’t many analytical CROs able to carry out Franz cell assays and Kymos’ pioneering work was pivotal for the registration of our product.

Dr. Pablo Avilés

PharmaMar Logo
quotation-mark

Kymos offered superior historical expertise by being exposed to so many different clients, pharmacological compounds, and therapeutic areas. They addressed and anticipated very diverse problems.

Jaime Algorta

Medical Affairs Director

quotation-mark

I have had a long and fruitful experience with Kymos and have a huge interest in their participation owing to their reliability.

OMEICOS THERAPEUTICS

Omeicos_Logo
quotation-mark

Prolytic is our analytical partner throughout the entire drug development process. Such a long and complex process requires a laboratory you can trust. Professional yet flexible, Prolytic accompanies us through the preclinical and clinical phases.

Dr. Meike Saul

Research Group Leader

quotation-mark

Establishing robust miRNA methods for valuable results is tricky. The team at Prolytic have been a key collaboration partner. With their 30 years of experience in bioanalytics and broad know-how in different techniques, study types, and substance groups, we were able to quickly develop a reproducible and reliable analysis method for miRNAs

Get in touch with us

Find a location near you